InsiderClue
← All stocks

Olema Pharmaceuticals, Inc.

OLMA Net buying
CIK 0001750284 #2588 in the set updated 20 Sep 2026
Bought (120 mo)
$88.75M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$95.43M
$3.55M on a plan · $22.47M straight out of an exercise
Sold at will
$69.42M
65 of 127 sales
Net
−$6.69M
+$19.33M against sales at will

By person

19 insiders · 162 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BVF PARTNERS L P/IL entity
Director
$44.14M (11)
—
+$44.14M
547,082
0.6253%
$6.41M
—
Paradigm Biocapital Advisors LP entity
10% owner
$1.16M (1)
$35.80M (2)
−$34.64M
783,118
0.8950%
$9.17M
−74.6%
Graham G. Walmsley
Director
$33.64M (6)
$22.18M (3)
+$11.46M
2,568,875
2.94%
$30.09M
+237.3%
Cormorant Asset Management, LP entity
Former 10% Owner
$8.08M (1)
—
+$8.08M
3,270,544
3.74%
$38.31M
—
Zojwalla Naseem
CHIEF MEDICAL OFFICER
—
$7.99M (10) scheduled
−$7.99M
4,488
0.0051%
$52.57K
−80.7%
CLARK IAN T
Director
—
$7.87M (3) scheduled
−$7.87M
0
0.0000%
$0.00
—
Harmon Cyrus
Director
—
$6.37M (50)
−$6.37M
941,826
1.08%
$11.03M
−8.2%
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
—
$5.61M (20) scheduled
−$5.61M
842,453
0.9628%
$9.87M
+38.8%
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
— (2)
$3.57M (8)
−$3.57M
139,727
0.1597%
$1.64M
+644.4%
Horn Kinney
Chief Business Officer
—
$2.98M (16) scheduled
−$2.98M
2,458
0.0028%
$28.79K
0.0%
Bohen Sean
PRESIDENT AND CEO
—
$2.11M (12)
−$2.11M
237,650
0.2716%
$2.78M
+806.1%
Bain Capital Life Sciences Investors, LLC entity
10% owner
$1.73M (1)
—
+$1.73M
4,300,000
4.91%
$50.37M
−42.7%
Mitchell Shawnte
CHIEF LEGAL OFFICER
—
$951.50K (3) scheduled
−$951.50K
0
0.0000%
$0.00
—
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% owner
—
—
—
1,725,406
1.97%
$20.21M
—
Kushner Peter J.
CHIEF SCIENTIFIC OFFICER
—
—
—
1,431,672
1.64%
$16.77M
+54.1%
RAPPAPORT ANDREW
Director
—
—
—
866,979
0.9909%
$10.16M
+68.8%
MCCORMICK FRANK
Director
—
—
—
275,373
0.3147%
$3.23M
+390.4%
BUTITTA CYNTHIA M
Director
—
—
—
83,876
0.0959%
$982.52K
—
Austin Sasha Lu
VP of Finance and Controller
—
—
—
16,188
0.0185%
$189.63K
+260.7%

Individual transactions

36
Insider
Date
Role
Action
Shares
Price
Amount
Mitchell Shawnte
4 Mar 2026
CHIEF LEGAL OFFICER
Sold after exercise
233
$24.69
$5.75K
Mitchell Shawnte
4 Mar 2026
CHIEF LEGAL OFFICER
Sold after exercise
24,767
$24.25
$600.60K
Mitchell Shawnte
3 Mar 2026
CHIEF LEGAL OFFICER
Sold after exercise
15,000
$23.01
$345.15K
Myles David C.
14 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
35,003
$28.99
$1.01M
Myles David C.
14 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
14,997
$28.60
$428.91K
Myles David C.
13 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
200
$28.49
$5.70K
Myles David C.
13 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
49,800
$27.60
$1.37M
Zojwalla Naseem
23 Dec 2025
Chief Medical Officer
Sold after exercise
99,509
$27.66
$2.75M
Zojwalla Naseem
22 Dec 2025
Chief Medical Officer
Sold after exercise
100,000
$28.04
$2.80M
Zojwalla Naseem
19 Dec 2025
Chief Medical Officer
Sold after exercise
12,921
$28.93
$373.80K
Zojwalla Naseem
19 Dec 2025
Chief Medical Officer
Sold after exercise
57,079
$28.03
$1.60M
CLARK IAN T
19 Dec 2025
Director
Sold after exercise
41,840
$30.48
$1.28M
CLARK IAN T
19 Dec 2025
Director
Sold after exercise
193,056
$29.71
$5.74M
CLARK IAN T
19 Dec 2025
Director
Sold after exercise
29,904
$28.83
$862.13K
Horn Kinney
10 Mar 2022
CHIEF BUSINESS OFFICER
Sold after exercise
5,253
$4.75
$24.95K
Horn Kinney
10 Jan 2022
CHIEF BUSINESS OFFICER
Sold after exercise
5,251
$6.85
$35.97K
Horn Kinney
10 Dec 2021
CHIEF BUSINESS OFFICER
Sold after exercise
5,251
$10.39
$54.56K
Horn Kinney
10 Nov 2021
CHIEF BUSINESS OFFICER
Sold after exercise
27,668
$26.88
$743.72K
Bohen Sean
14 Oct 2021
PRESIDENT AND CEO
Sold after exercise
351
$31.17
$10.94K
Bohen Sean
14 Oct 2021
PRESIDENT AND CEO
Sold after exercise
4,649
$30.42
$141.42K
Horn Kinney
11 Oct 2021
CHIEF BUSINESS OFFICER
Sold after exercise
3,146
$28.19
$88.69K
Horn Kinney
11 Oct 2021
CHIEF BUSINESS OFFICER
Sold after exercise
2,105
$27.47
$57.82K
Bohen Sean
27 Sep 2021
PRESIDENT AND CEO
Sold after exercise
1,085
$30.07
$32.63K
Horn Kinney
10 Sep 2021
CHIEF BUSINESS OFFICER
Sold after exercise
5,251
$29.38
$154.27K
Bohen Sean
8 Sep 2021
PRESIDENT AND CEO
Sold after exercise
2,631
$30.00
$78.93K
Bohen Sean
7 Sep 2021
PRESIDENT AND CEO
Sold after exercise
413
$30.08
$12.42K
Bohen Sean
1 Sep 2021
PRESIDENT AND CEO
Sold after exercise
871
$30.05
$26.17K
Horn Kinney
10 Aug 2021
CHIEF BUSINESS OFFICER
Sold after exercise
60
$26.17
$1.57K
Horn Kinney
10 Aug 2021
CHIEF BUSINESS OFFICER
Sold after exercise
5,191
$25.70
$133.41K
Horn Kinney
12 Jul 2021
CHIEF BUSINESS OFFICER
Sold after exercise
1,392
$27.00
$37.58K
Horn Kinney
12 Jul 2021
CHIEF BUSINESS OFFICER
Sold after exercise
3,859
$26.33
$101.61K
Horn Kinney
10 Jun 2021
CHIEF BUSINESS OFFICER
Sold after exercise
2,787
$29.97
$83.53K
Horn Kinney
10 Jun 2021
CHIEF BUSINESS OFFICER
Sold after exercise
2,164
$29.60
$64.05K
Horn Kinney
10 Jun 2021
CHIEF BUSINESS OFFICER
Sold after exercise
300
$28.30
$8.49K
Horn Kinney
18 May 2021
CHIEF BUSINESS OFFICER
Sold after exercise
8,621
$24.81
$213.89K
Horn Kinney
18 May 2021
CHIEF BUSINESS OFFICER
Sold after exercise
49,142
$24.03
$1.18M
Show all 162 transactions →

What was left out

Form 4 filings counted 203
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 36
Sales at will 65
Transactions with no price 2
Shares from compensation/vesting 24,931,528
Sales filed before the plan box existed 11
History held since 19 Nov 2020